5-(Azetidin-3-yl)-3-(4-methyl-3-nitrophenyl)-1,2,4-oxadiazole, 97%, 500mg

Ethyl 2-(2-aminoacetamido)acetate hydrochloride, 95.0%, 10g

4-Chloro-5-methoxypyrimidine, 95.0%, 100mg

2-(4-Methoxybenzyl)-5-methyl-2H-pyrazol-3-ylamine, 95.0%, 1g

6-Bromo-7-fluoro-3h-1,3-benzothiazole-2-thione, 98%, 100mg

5-(4-Bromophenyl)-4-chlorothieno[2,3-d]pyrimidine, 97%, 250mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 100, 500 ml, 130 mm, 1 Piece

2-Methyl-1-naphthyl Acetate>98.0%(GC)250g

TRIOCTANOIN, 95%, 500g

Copper(I) bromide dimethyl sulfide complex, 98.0%, 5g

4-Hydroxy-3-iodobenzoic acid, 95.0%, 5g

2-Cyclopropylmorpholine hydrochloride, 97%, 1g

3-(tert-Butyl)-4-(3,5-diisopropyl-2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97.00%, 100mg